Literature DB >> 28038729

2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castellá, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28038729     DOI： 10.1016/j.rec.2016.11.033

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN： 1885-5857


× No keyword cloud information.
  74 in total

Review 1.  Population-Based Screening for Atrial Fibrillation.

Authors:  Shaan Khurshid; Jeffrey S Healey; William F McIntyre; Steven A Lubitz
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Anticoagulation in atrial fibrillation: NOAC prescribing in primary health care.

Authors:  Carla Bastida; Núria Corominas; José Miguel Sotoca; Marina Rovira
Journal:  Int J Clin Pharm       Date:  2017-02-10

Review 3.  Insight into atrial fibrillation through analysis of the coding transcriptome in humans.

Authors:  Marja Steenman
Journal:  Biophys Rev       Date:  2020-07-15

4.  Clinical outcomes after AF cardioversion in patients presenting left atrial sludge in trans-esophageal echocardiography.

Authors:  Fabien Squara; Mikael Bres; Didier Scarlatti; Pamela Moceri; Emile Ferrari
Journal:  J Interv Card Electrophysiol       Date:  2019-05-22       Impact factor: 1.900

5.  Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.

Authors:  Anne Katrine Eek; Erik Øie; Anne Gerd Granas
Journal:  Eur J Clin Pharmacol       Date:  2017-11-17       Impact factor: 2.953

6.  OCULUS study: Virtual reality-based education in daily clinical practice.

Authors:  Paweł Balsam; Sonia Borodzicz; Karolina Malesa; Dominika Puchta; Agata Tymińska; Krzysztof Ozierański; Łukasz Kołtowski; Michał Peller; Marcin Grabowski; Krzysztof J Filipiak; Grzegorz Opolski
Journal:  Cardiol J       Date:  2018-01-03       Impact factor: 2.737

7.  Oral Anticoagulant Utilization in the United States and United Kingdom.

Authors:  Michael Colacci; Eric K Tseng; Chana A Sacks; Michael Fralick
Journal:  J Gen Intern Med       Date:  2020-06-08       Impact factor: 5.128

Review 8.  Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure.

Authors:  Felix Hohendanner; F R Heinzel; F Blaschke; B M Pieske; W Haverkamp; H L Boldt; A S Parwani
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

9.  Efficacy and Safety of Direct Oral Anticoagulants in Elderly Patients With Atrial Fibrillation: A Network Meta-Analysis.

Authors:  Kaisheng Deng; Jinqun Cheng; Shufang Rao; Huafu Xu; Lixia Li; Yanhui Gao
Journal:  Front Med (Lausanne)       Date:  2020-04-07

10.  Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.

Authors:  Stefan H Hohnloser; John Camm; Riccardo Cappato; Hans-Christoph Diener; Hein Heidbuchel; Hans-Joachim Lanz; Lluís Mont; Carlos A Morillo; Rüdiger Smolnik; Ophelia Q P Yin; Josef Kautzner
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.